Recent advances in drug repositioning for the discovery of new anticancer drugs

Joong Sup Shim, Jun Liu

Research output: Contribution to journalArticle

Abstract

Drug repositioning (also referred to as drug repurposing), the process of finding new uses of existing drugs, has been gaining popularity in recent years. The availability of several established clinical drug libraries and rapid advances in disease biology, genomics and bioinformatics has accelerated the pace of both activity-based and in silico drug repositioning. Drug repositioning has attracted particular attention from the communities engaged in anticancer drug discovery due to the combination of great demand for new anticancer drugs and the availability of a wide variety of cell-and target-based screening assays. With the successful clinical introduction of a number of non-cancer drugs for cancer treatment, drug repositioning now became a powerful alternative strategy to discover and develop novel anticancer drug candidates from the existing drug space. In this review, recent successful examples of drug repositioning for anticancer drug discovery from non-cancer drugs will be discussed.

Original languageEnglish (US)
Pages (from-to)654-663
Number of pages10
JournalInternational Journal of Biological Sciences
Volume10
Issue number7
DOIs
StatePublished - Jun 10 2014

Fingerprint

Drug Repositioning
new drugs
antineoplastic agents
Drug Discovery
drug
drugs
Pharmaceutical Preparations
Genomics
Computational Biology
Computer Simulation
bioinformatics
drug therapy

Keywords

  • Angiogenesis
  • Cancer
  • Drug discovery
  • Drug library
  • Drug repositioning
  • Drug screening

ASJC Scopus subject areas

  • Molecular Biology
  • Ecology, Evolution, Behavior and Systematics
  • Applied Microbiology and Biotechnology
  • Cell Biology
  • Developmental Biology
  • Medicine(all)

Cite this

Recent advances in drug repositioning for the discovery of new anticancer drugs. / Shim, Joong Sup; Liu, Jun.

In: International Journal of Biological Sciences, Vol. 10, No. 7, 10.06.2014, p. 654-663.

Research output: Contribution to journalArticle

@article{d21d4639064d4a5db6e0074d924feb5d,
title = "Recent advances in drug repositioning for the discovery of new anticancer drugs",
abstract = "Drug repositioning (also referred to as drug repurposing), the process of finding new uses of existing drugs, has been gaining popularity in recent years. The availability of several established clinical drug libraries and rapid advances in disease biology, genomics and bioinformatics has accelerated the pace of both activity-based and in silico drug repositioning. Drug repositioning has attracted particular attention from the communities engaged in anticancer drug discovery due to the combination of great demand for new anticancer drugs and the availability of a wide variety of cell-and target-based screening assays. With the successful clinical introduction of a number of non-cancer drugs for cancer treatment, drug repositioning now became a powerful alternative strategy to discover and develop novel anticancer drug candidates from the existing drug space. In this review, recent successful examples of drug repositioning for anticancer drug discovery from non-cancer drugs will be discussed.",
keywords = "Angiogenesis, Cancer, Drug discovery, Drug library, Drug repositioning, Drug screening",
author = "Shim, {Joong Sup} and Jun Liu",
year = "2014",
month = "6",
day = "10",
doi = "10.7150/ijbs.9224",
language = "English (US)",
volume = "10",
pages = "654--663",
journal = "International Journal of Biological Sciences",
issn = "1449-2288",
publisher = "Ivyspring International Publisher",
number = "7",

}

TY - JOUR

T1 - Recent advances in drug repositioning for the discovery of new anticancer drugs

AU - Shim, Joong Sup

AU - Liu, Jun

PY - 2014/6/10

Y1 - 2014/6/10

N2 - Drug repositioning (also referred to as drug repurposing), the process of finding new uses of existing drugs, has been gaining popularity in recent years. The availability of several established clinical drug libraries and rapid advances in disease biology, genomics and bioinformatics has accelerated the pace of both activity-based and in silico drug repositioning. Drug repositioning has attracted particular attention from the communities engaged in anticancer drug discovery due to the combination of great demand for new anticancer drugs and the availability of a wide variety of cell-and target-based screening assays. With the successful clinical introduction of a number of non-cancer drugs for cancer treatment, drug repositioning now became a powerful alternative strategy to discover and develop novel anticancer drug candidates from the existing drug space. In this review, recent successful examples of drug repositioning for anticancer drug discovery from non-cancer drugs will be discussed.

AB - Drug repositioning (also referred to as drug repurposing), the process of finding new uses of existing drugs, has been gaining popularity in recent years. The availability of several established clinical drug libraries and rapid advances in disease biology, genomics and bioinformatics has accelerated the pace of both activity-based and in silico drug repositioning. Drug repositioning has attracted particular attention from the communities engaged in anticancer drug discovery due to the combination of great demand for new anticancer drugs and the availability of a wide variety of cell-and target-based screening assays. With the successful clinical introduction of a number of non-cancer drugs for cancer treatment, drug repositioning now became a powerful alternative strategy to discover and develop novel anticancer drug candidates from the existing drug space. In this review, recent successful examples of drug repositioning for anticancer drug discovery from non-cancer drugs will be discussed.

KW - Angiogenesis

KW - Cancer

KW - Drug discovery

KW - Drug library

KW - Drug repositioning

KW - Drug screening

UR - http://www.scopus.com/inward/record.url?scp=84902357848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902357848&partnerID=8YFLogxK

U2 - 10.7150/ijbs.9224

DO - 10.7150/ijbs.9224

M3 - Article

VL - 10

SP - 654

EP - 663

JO - International Journal of Biological Sciences

JF - International Journal of Biological Sciences

SN - 1449-2288

IS - 7

ER -